CSIMarket



Worst Performing Stocks In Medical Equipment & Supplies Industry 2024 Year To Date



 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 
 

Shares increased by 4.16% on average, in Medical Equipment & Supplies Industry 2024 year to date.

Here are the Worst performing stocks in Medical Equipment & Supplies Industry.




XRAY

$27.525

$-8.1050 -22.75%
2024 Year to Date


XRAY

$27.525

$-8.1050 -22.75%



Dentsply Sirona Inc

Dentsply Sirona Inc stock declined -22.75% 2024 year to date.


Dentsply Sirona Inc is a leading dental solutions provider, offering a comprehensive portfolio of dental products and technologies. Their business model focuses on manufacturing and distributing dental equipment, consumables, and digital dentistry solutions to dental professionals worldwide. By combining innovation, research, and customer-centricity, they strive to empower dental professionals to deliver the best possible patient care.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5,738.963 mill. $ 3,906.000 mill. $ -187.000 mill. 209 mill. - Y/Y -3.05 %
Market Cap. Revenues TTM Net Income TTM

$ 5,738.963 mill.


$ 3,906.000 mill.


$ -187.000 mill.

Employees Shares Outstanding P/E

15,000


209 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -3.05 %


MRQ Y/Y - %



ZBH

$111.27

$-10.1200 -8.34%
2024 Year to Date


ZBH

$111.27

$-10.1200 -8.34%



Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc stock declined -8.34% 2024 year to date.


Zimmer Biomet Holdings Inc operates as a global leader in musculoskeletal healthcare, providing innovative solutions for joint replacement, sports medicine, spine, dental implants, and other surgical products. The company*s business model centers around designing, manufacturing, and marketing these medical devices and equipment to healthcare professionals worldwide, with a focus on improving patient outcomes and advancing the field of musculoskeletal healthcare.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 23,366.700 mill. $ 7,279.300 mill. $ 475.200 mill. 210 mill. 49.25 Y/Y 5.02 %
Market Cap. Revenues TTM Net Income TTM

$ 23,366.700 mill.


$ 7,279.300 mill.


$ 475.200 mill.

Employees Shares Outstanding P/E

19,500


210 mill.


49.25

Revenue Growth Income Growth

MRQ Y/Y 5.02 %


MRQ Y/Y -16.12 %



TFX

$230.065

$-20.3750 -8.14%
2024 Year to Date


TFX

$230.065

$-20.3750 -8.14%



Teleflex Incorporated

Teleflex Incorporated shares dropped -8.14% 2024 year to date.


Teleflex Incorporated operates with a diversified business model focused on the design, development, manufacturing, and distribution of specialty medical devices. The company offers a wide range of products and solutions across multiple medical fields, including critical care, surgical, and respiratory care. Teleflex*s business model centers around providing innovative, high-quality medical technologies to healthcare professionals globally, aiming to improve patient outcomes and enhance procedural efficiency.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 10,903.701 mill. $ 3,000.133 mill. $ 294.869 mill. 47 mill. 36.95 Y/Y 3.69 %
Market Cap. Revenues TTM Net Income TTM

$ 10,903.701 mill.


$ 3,000.133 mill.


$ 294.869 mill.

Employees Shares Outstanding P/E

14,000


47 mill.


36.95

Revenue Growth Income Growth

MRQ Y/Y 3.69 %


MRQ Y/Y -80.08 %



BAX

$35.725

$-3.1250 -8.04%
2024 Year to Date


BAX

$35.725

$-3.1250 -8.04%



Baxter International Inc

Baxter International Inc shares declined -8.04% 2024 year to date.


Baxter International Inc is a global healthcare company that specializes in providing a wide range of medical products and services. They operate through various business segments including Pharmaceuticals, Medical Products, and Renal Care, offering solutions for hospitals, clinics, and home-based healthcare settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 18,219.750 mill. $ 14,756.000 mill. $ 2,657.000 mill. 510 mill. 6.87 Y/Y -1.56 %
Market Cap. Revenues TTM Net Income TTM

$ 18,219.750 mill.


$ 14,756.000 mill.


$ 2,657.000 mill.

Employees Shares Outstanding P/E

60,000


510 mill.


6.87

Revenue Growth Income Growth

MRQ Y/Y -1.56 %


MRQ Y/Y -13.33 %



PDCO

$26.41

$-2.2800 -7.95%
2024 Year to Date


PDCO

$26.41

$-2.2800 -7.95%



Patterson Companies Inc

Patterson Companies Inc stock declined -7.95% 2024 year to date.


Patterson Companies Inc*s business model focuses on distributing and selling a wide range of products and solutions to various industries, including dental, animal health, and rehabilitation.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,443.427 mill. $ 6,565.239 mill. $ 193.420 mill. 93 mill. 13.01 Y/Y 0.95 %
Market Cap. Revenues TTM Net Income TTM

$ 2,443.427 mill.


$ 6,565.239 mill.


$ 193.420 mill.

Employees Shares Outstanding P/E

7,000


93 mill.


13.01

Revenue Growth Income Growth

MRQ Y/Y 0.95 %


MRQ Y/Y -11.61 %



HSIC

$70.935

$-4.6250 -6.12%
2024 Year to Date


HSIC

$70.935

$-4.6250 -6.12%



Henry Schein Inc

Henry Schein Inc shares went down -6.12% 2024 year to date.


Henry Schein Inc is a global distributor of healthcare products, services, and technology solutions to dental and medical professionals. They operate through a vast network of sales consultants, offering a wide range of products from various manufacturers to meet their customers* needs. Their business model focuses on providing high-quality products, innovative solutions, and superior customer service to enhance patient care and improve practice efficiency.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9,205.205 mill. $ 12,451.000 mill. $ 406.000 mill. 130 mill. 23.89 Y/Y 3.66 %
Market Cap. Revenues TTM Net Income TTM

$ 9,205.205 mill.


$ 12,451.000 mill.


$ 406.000 mill.

Employees Shares Outstanding P/E

21,600


130 mill.


23.89

Revenue Growth Income Growth

MRQ Y/Y 3.66 %


MRQ Y/Y -23.44 %



PODD

$196.52

$-12.5900 -6.02%
2024 Year to Date


PODD

$196.52

$-12.5900 -6.02%



Insulet Corporation

Insulet Corporation shares dropped -6.02% 2024 year to date.


Insulet Corporation operates under a business model where they design, develop, and market innovative tubeless insulin delivery systems for people with diabetes. Their main product, the Omnipod System, is a wearable device that provides continuous insulin delivery without the need for traditional insulin pumps and tubing. This unique business model focuses on improving the quality of life for individuals with diabetes by offering a convenient and user-friendly insulin management solution.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 14,491.581 mill. $ 1,780.700 mill. $ 234.000 mill. 74 mill. 63.87 Y/Y 23.35 %
Market Cap. Revenues TTM Net Income TTM

$ 14,491.581 mill.


$ 1,780.700 mill.


$ 234.000 mill.

Employees Shares Outstanding P/E

3,500


74 mill.


63.87

Revenue Growth Income Growth

MRQ Y/Y 23.35 %


MRQ Y/Y 116.39 %



MMM

$104.54

$-5.4600 -4.96%
2024 Year to Date


MMM

$104.54

$-5.4600 -4.96%



3m Company

3m Company shares declined -4.96% 2024 year to date.


3M Company is a diversified technology company that operates through various business segments. It focuses on innovation and develops a wide range of products across industries such as healthcare, transportation, consumer goods, and electronics. Its business model involves creating innovative solutions, leveraging its vast portfolio of patents, and maintaining strong relationships with customers and suppliers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 58,113.786 mill. $ 32,653.000 mill. $ -7,027.000 mill. 556 mill. - Y/Y -0.35 %
Market Cap. Revenues TTM Net Income TTM

$ 58,113.786 mill.


$ 32,653.000 mill.


$ -7,027.000 mill.

Employees Shares Outstanding P/E

95,000


556 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -0.35 %


MRQ Y/Y -4.89 %



BDX

$234.23

$-11.1900 -4.56%
2024 Year to Date


BDX

$234.23

$-11.1900 -4.56%



Becton Dickinson And Company

Becton Dickinson And Company stock went down -4.56% 2024 year to date.


Becton Dickinson and Company is a global medical technology company that manufactures and sells a wide range of medical devices, instruments, and reagents. They operate under a business model centered around delivering innovative healthcare solutions to improve patient outcomes and enhance clinical efficiencies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 67,990.005 mill. $ 19,716.000 mill. $ 1,332.000 mill. 290 mill. 51.63 Y/Y 4.65 %
Market Cap. Revenues TTM Net Income TTM

$ 67,990.005 mill.


$ 19,716.000 mill.


$ 1,332.000 mill.

Employees Shares Outstanding P/E

77,000


290 mill.


51.63

Revenue Growth Income Growth

MRQ Y/Y 4.65 %


MRQ Y/Y 16.49 %



MDT

$81.03

$-1.8100 -2.18%
2024 Year to Date


MDT

$81.03

$-1.8100 -2.18%



Medtronic Plc

Medtronic Plc stock went down -2.18% 2024 year to date.


Medtronic Plc is a global medical technology company that operates primarily through four business segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. Their business model revolves around designing, manufacturing, and distributing medical devices and therapies for the treatment of a wide range of medical conditions, including cardiovascular diseases, neurological disorders, and diabetes. Medtronic Plc also focuses on collaborating with healthcare providers to improve patient outcomes and reduce healthcare costs through innovative solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 107,922.565 mill. $ 32,364.000 mill. $ 3,705.000 mill. 1,332 mill. 29.42 Y/Y 0.53 %
Market Cap. Revenues TTM Net Income TTM

$ 107,922.565 mill.


$ 32,364.000 mill.


$ 3,705.000 mill.

Employees Shares Outstanding P/E

95,000


1,332 mill.


29.42

Revenue Growth Income Growth

MRQ Y/Y 0.53 %


MRQ Y/Y -44.49 %



SYK

$336.66

$40.4300 13.65%
2024 Year to Date


SYK

$336.66

$40.4300 13.65%



Stryker Corp

Stryker Corp stock improved 13.65% 2024 year to date.


Stryker Corp*s business model is based on developing and manufacturing a wide range of medical technologies and devices for the healthcare industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 129,647.766 mill. $ 20,963.000 mill. $ 3,361.000 mill. 385 mill. 38.51 Y/Y 9.73 %
Market Cap. Revenues TTM Net Income TTM

$ 129,647.766 mill.


$ 20,963.000 mill.


$ 3,361.000 mill.

Employees Shares Outstanding P/E

46,000


385 mill.


38.51

Revenue Growth Income Growth

MRQ Y/Y 9.73 %


MRQ Y/Y 33.11 %



ISRG

$429.04

$98.0600 29.63%
2024 Year to Date


ISRG

$429.04

$98.0600 29.63%



Intuitive Surgical Inc

Intuitive Surgical Inc stock went up 29.63% 2024 year to date.


Intuitive Surgical Inc*s business model revolves around providing robotic surgical systems, instruments, and accessories to hospitals and healthcare facilities. Their flagship product, the da Vinci Surgical System, enables surgeons to perform minimally invasive surgeries with enhanced precision and control. The company generates revenue through the sale of these systems and associated instruments, as well as through training, services, and maintenance provided to its customers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 154,668.920 mill. $ 7,317.700 mill. $ 2,003.900 mill. 361 mill. 77.25 Y/Y 11.45 %
Market Cap. Revenues TTM Net Income TTM

$ 154,668.920 mill.


$ 7,317.700 mill.


$ 2,003.900 mill.

Employees Shares Outstanding P/E

9,793


361 mill.


77.25

Revenue Growth Income Growth

MRQ Y/Y 11.45 %


MRQ Y/Y 51.72 %



BSX

$77.39

$19.5500 33.80%
2024 Year to Date


BSX

$77.39

$19.5500 33.80%



Boston Scientific Corporation

Boston Scientific Corporation stock increased 33.80% 2024 year to date.


Boston Scientific Corporation*s business model revolves around designing, developing, and manufacturing a wide range of medical devices that are used in various medical specialties. The company focuses on creating innovative products that address unmet medical needs and improve patient outcomes. They sell these devices to healthcare professionals and hospitals worldwide, leveraging their strong sales and distribution networks. Additionally, Boston Scientific actively invests in research and development to continuously bring new technologies and solutions to the market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 114,668.763 mill. $ 14,709.000 mill. $ 1,771.000 mill. 1,482 mill. 67.12 Y/Y 13.81 %
Market Cap. Revenues TTM Net Income TTM

$ 114,668.763 mill.


$ 14,709.000 mill.


$ 1,771.000 mill.

Employees Shares Outstanding P/E

41,000


1,482 mill.


67.12

Revenue Growth Income Growth

MRQ Y/Y 13.81 %


MRQ Y/Y 57.01 %




 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com